Triple

T8809212
Position Surface form Disambiguated ID Type / Status
Subject Frederick National Laboratory for Cancer Research E209613 entity
Predicate operatedBy P86 FINISHED
Object Leidos Biomedical Research, Inc.
Leidos Biomedical Research, Inc. is a U.S.-based life sciences and biomedical research organization that manages and conducts advanced cancer and infectious disease research for federal agencies.
E759507 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Leidos Biomedical Research, Inc. | Statement: [Frederick National Laboratory for Cancer Research, operatedBy, Leidos Biomedical Research, Inc.]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Leidos Biomedical Research, Inc.
Context triple: [Frederick National Laboratory for Cancer Research, operatedBy, Leidos Biomedical Research, Inc.]
  • A. Battelle Memorial Institute
    Battelle Memorial Institute is a major nonprofit applied science and technology organization known for managing national laboratories and conducting research and development across defense, energy, health, and environmental domains.
  • B. U.S. Army Medical Research Acquisition Activity
    The U.S. Army Medical Research Acquisition Activity is a military contracting and procurement organization that manages medical research and development acquisitions for the U.S. Army.
  • C. Hudson Laboratories
    Hudson Laboratories was a research organization known for its work in underwater acoustics and oceanographic studies, particularly in support of U.S. Navy and defense-related projects.
  • D. Rome Laboratory
    Rome Laboratory was a U.S. Air Force research center specializing in information and communications technologies that later became part of the Air Force Research Laboratory.
  • E. Draper Laboratory
    Draper Laboratory is a nonprofit research and development organization known for its pioneering work in guidance, navigation, and control systems and other advanced engineering technologies.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Leidos Biomedical Research, Inc.
Triple: [Frederick National Laboratory for Cancer Research, operatedBy, Leidos Biomedical Research, Inc.]
Generated description
Leidos Biomedical Research, Inc. is a U.S.-based life sciences and biomedical research organization that manages and conducts advanced cancer and infectious disease research for federal agencies.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Leidos Biomedical Research, Inc.
Target entity description: Leidos Biomedical Research, Inc. is a U.S.-based life sciences and biomedical research organization that manages and conducts advanced cancer and infectious disease research for federal agencies.
  • A. Battelle Memorial Institute
    Battelle Memorial Institute is a major nonprofit applied science and technology organization known for managing national laboratories and conducting research and development across defense, energy, health, and environmental domains.
  • B. U.S. Army Medical Research Acquisition Activity
    The U.S. Army Medical Research Acquisition Activity is a military contracting and procurement organization that manages medical research and development acquisitions for the U.S. Army.
  • C. Hudson Laboratories
    Hudson Laboratories was a research organization known for its work in underwater acoustics and oceanographic studies, particularly in support of U.S. Navy and defense-related projects.
  • D. Rome Laboratory
    Rome Laboratory was a U.S. Air Force research center specializing in information and communications technologies that later became part of the Air Force Research Laboratory.
  • E. Draper Laboratory
    Draper Laboratory is a nonprofit research and development organization known for its pioneering work in guidance, navigation, and control systems and other advanced engineering technologies.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca8363f3308190a47e3f1ebd51f613 completed March 30, 2026, 2:06 p.m.
NER Named-entity recognition batch_69cc5fd4cbec8190a929d4e60da8ad65 completed March 31, 2026, 11:59 p.m.
NED1 Entity disambiguation (via context triple) batch_69cf6fa0e4308190bd01c2d107c8c02d completed April 3, 2026, 7:43 a.m.
NEDg Description generation batch_69cf718a6f2c81908f8b8d08a1437749 completed April 3, 2026, 7:51 a.m.
NED2 Entity disambiguation (via description) batch_69cf7275fea08190b8999fb30663ff17 completed April 3, 2026, 7:55 a.m.
Created at: March 30, 2026, 6:45 p.m.